Xcout IntelReglagene Holding, Inc.
Reglagene Holding, Inc. is a biotechnology company developing brain-penetrant oral therapies for central nervous system oncology. Its lead small molecule candidate, RGN6024, is…
The full profile of Reglagene Holding, Inc.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Reglagene Holding, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Reglagene Holding, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.